丹, 韩., 飞, 于., 朱昕桐, 玥, 武., 尉, 邵., & 李睿旻. (2026). 医保情景下利司扑兰治疗儿童脊髓性肌萎缩症的经济学评价. Journal of Pharmaceutical Practice & Service, 44(8), 431. https://doi.org/10.12206/j.issn.2097-2024.202601017
Chicago Style (17th ed.) Citation丹, 韩, 于 飞, 朱昕桐, 武 玥, 邵 尉, and 李睿旻. "医保情景下利司扑兰治疗儿童脊髓性肌萎缩症的经济学评价." Journal of Pharmaceutical Practice & Service 44, no. 8 (2026): 431. https://doi.org/10.12206/j.issn.2097-2024.202601017.
MLA (9th ed.) Citation丹, 韩, et al. "医保情景下利司扑兰治疗儿童脊髓性肌萎缩症的经济学评价." Journal of Pharmaceutical Practice & Service, vol. 44, no. 8, 2026, p. 431, https://doi.org/10.12206/j.issn.2097-2024.202601017.
Warning: These citations may not always be 100% accurate.
